Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Poster

Using artificial intelligence to distinguish subjects with prostate cancer (PCa) from benign prostatic hyperplasia (BPH) through immunophenotyping of MDSCs and lymphocyte cell populations

Presentation Poster

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

Read More...

Anixa Biosciences Conference Call Recording Available on Company Website

Read More...

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.